Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT02500381 · COMPLETED
Trial details
- NCT number
- NCT02500381
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2024-11-12
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.